SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-106103
Filing Date
2016-06-01
Accepted
2016-06-01 08:50:21
Documents
8
Period of Report
2016-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v441440_8k.htm 8-K 28520
2 EXHIBIT 4.1 v441440_ex4-1.htm EX-4.1 87551
3 EXHIBIT 5.1 v441440_ex5-1.htm EX-5.1 15795
4 EXHIBIT 99.1 v441440_ex99-1.htm EX-99.1 13755
5 EXHIBIT 99.2 v441440_ex99-2.htm EX-99.2 108906
6 EXHIBIT 99.3 v441440_ex99-3.htm EX-99.3 195164
7 GRAPHIC tex5-1logo.jpg GRAPHIC 9464
8 GRAPHIC tex99-1logo.jpg GRAPHIC 13863
  Complete submission text file 0001144204-16-106103.txt   483377
Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 161688007
SIC: 2836 Biological Products, (No Diagnostic Substances)